Tatyana P. Khramykh

Tatyana P. Khramykh

Auto-generated profile, based on publicly available information

Tatyana P. Khramykh

Omsk State Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
GKG.M. Kostanyan
G.M. Kostanyan
TKT.P. Khramykh
T.P. Khramykh
TGT.I. Gaygiev
T.I. Gaygiev
PEP.A. Ermolaev
P.A. Ermolaev
MKM.V. Kolbina
M.V. Kolbina
KMK.P. Memus
K.P. Memus
Несмотря на достижения современной медицины, сахарный диабет остается одной из самых распространенных эндокринопатий в мире. В клинических исследованиях последних лет показано, что тяжесть и длительность течения сахарного диабета тесно ассоциированы с развитием поражений сосудистой стенки (так называемой микро- и макроангиопатии), одним из тяжелых клинических проявлений которых является поражение артериального русла нижних конечностей с формированием трофических и гнойно-некротических изменений в мягких тканях стопы (синдром диабетической стопы), связанных с риском потери конечности. В обзоре проанализированы современные возможности рентгенэндоваскулярного лечения пациентов с ишемией нижних конечностей на фоне сахарного диабета. Обозначены особенности рентгенэндоваскулярных вмешательств на основе клинико-патоморфологических особенностей поражения сосудов у пациентов с сахарным диабетом. Проведен сравнительный анализ результатов открытого хирургического и рентгенэндоваскулярного лечения пациентов с ишемией нижних конечностей и обозначены дальнейшие перспективы по улучшению лечения таких пациентов.

20 April 2019 in Novosti Khirurgii
Verified
Journal Article
Closed access
OUOmsk State Medical University
Omsk State Medical University
VNV.N. Nikitin
V.N. Nikitin
VPV.L. Poluektov
V.L. Poluektov
TKT.P. Khramykh
T.P. Khramykh
LBL.O. Barskaya
L.O. Barskaya
VEV.P. Efanov
V.P. Efanov

28 February 2025 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
ПЕПавел Александрович Ермолаев
Павел Александрович Ермолаев
TKTatyana P. Khramykh
Tatyana P. Khramykh
Dmitry FilimonovDmitry Filimonov
Dmitry Filimonov
RIRoman V. Ishchenko
Roman V. Ishchenko
ИЭИван Васильевич Эманулиди
Иван Васильевич Эманулиди
МХМаксим Леонидович Хавандеев
Максим Леонидович Хавандеев
HighlightsThe article deepens the understanding of the pathogenesis of brain death in potential organ donors and, in particular, clarifies information on the dynamics of hemodynamic disorders and their contribution to the somatic survival of potential donors, which constitutes the scientific novelty of the study. AbstractAim. To study the development of early central hemodynamic disturbances and evaluate the somatic survival of experimental organ donor animals using an experimental model of brain deathMethods. The experiments were carried out on mature outbred male rats (n = 50). The experimental animals of experimental group №1 (n = 20, normotensive individuals, optimal donors) were anesthetized, invasive mean arterial pressure (MAP) and heart rate (HR) were recorded. Brain death was modeled by creating intracranial pneumopression. For conditioning the potential donor with brain death mean BP and HR were recorded for 3 hours; when mean BP dropped below 75 mm Hg, Gelofusin solution (B. Braun medical, AG, Switzerland) was infused. Animals from experimental group №2 (n = 20, hypotensive individuals, “marginal” donors) were anesthetized, then brain death was modeled in them, and mean BP and HR were monitored in the same way as in experimental group №1, but without correction of developing hemodynamic disorders. Intact anesthetized intubated animals (n = 10), whose hemodynamic parameters were recorded, served as controls.Results. After 30 minutes from the beginning of the experiment and further at all observation periods, a decrease in mean BP and HR was observed in the groups of normotensive and hypotensive animals compared to the control. By the end of the third hour of the experiment, despite volemic support, in normotensive animals, mean BP decreased to 60 [61; 67] mm Hg (p = 0.01 compared to the control), HR to 250 [248; 260] beats/min (p = 0.03 compared to the control). In the group of hypotensive animals, the dynamics of the decrease in mean BP was more pronounced and by the end of the third hour of the experiment, mean BP was 45 [41; 46] mm Hg (p = 0.01 compared to the control and normotensive animals), HR – 230 [224; 237] beats/min (p = 0.03 compared to the control and normotensive animals). In the normotensive group of animals, death due to progression of circulatory failure occurred in 8 individuals, the mortality rate was 40%, p = 0.02 compared with the control. In the hypotensive group of animals, death occurred in 14 individuals, the mortality rate was 60%, p = 0.01 compared with the control and normotensive animals.Conclusion. The results of the study of early central hemodynamic disturbances in an experiment on a brain death model indicate the development of more pronounced circulatory failure in marginal donors, which is accompanied by an increase in their mortality within 3 hours after the induction of brain death in comparison with optimal donors. Correction of systemic perfusion disturbances by volemic loading leads to an improvement in hemodynamic parameters and somatic survival of potential donors.

2 July 2025 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Open access
PDF file
PEPavel A. Ermolaev
Pavel A. Ermolaev
TKTatyana P. Khramykh
Tatyana P. Khramykh
LBLyubov O. Barskaya
Lyubov O. Barskaya
ХПХрамых Татьяна Петровна
Храмых Татьяна Петровна
БОБарская Любовь Олеговна
Барская Любовь Олеговна
INTRODUCTION: Extracorporeal perfusion of transplants is a promising area that is actively studied to eliminate the existing shortage of donor organs. However, the optimal parameters and duration of extracorporeal perfusion that would not lead to impairment of the morphofunctional condition of transplants, have not been sufficiently studied. AIM: To present the results of development and experimental testing of an original device for perfusion preservation of an isolated heart on the biomodel. MATERIALS AND METHODS: An original perfusion device for preserving donor hearts has been developed and experimentally tested on mature outbred male rats. During 15-hour normothermic extracorporeal perfusion of the heart in the proposed device, its rhythmic and contractile function, temperature, pH of the perfusate, pressure in the aorta, hematocrit, рО2 and рСО2 in the perfusate were studied, the content of glucose, lactate, and creatine phosphokinase (CPK) activity in perfusate samples were determined. RESULTS: During perfusion of isolated hearts, sinus rhythm was observed at a sufficient rate. Perfusate pH stayed within 7.3–7.4. Hearts were perfused at constant pressure in the aorta of 70 mm Hg in normothermic conditions (t=37°С). After stabilization of the heart function, the systolic pressure in the left ventricle was 96.0 [93.7; 98.5] mm Hg and remained without significant changes during 12 hours of perfusion; at 15 hours of perfusion, the parameter decreased by 15.0% to 82.0 [79.5; 84.2] mm Hg, p=0.01208. After stabilization of the heart function, diastolic pressure in the left ventricle was 4.0 [3.0; 5.0] mm Hg and remained without significant changes during 12 hours of perfusion; by 15 hours of perfusion, it increased 1.5 times to 6.0 [5.0; 7.0] mm Hg, p=0.0164. During the experiment, biochemical markers in the perfusate after 30 min of perfusion and stabilization were at the level of physiological values without significant dynamics within 12 hours of perfusion: glucose consumption was 80.5 [70.2; 85.5] μmol/(kg×min×mm Hg); lactate excretion — 35.7 [32.5; 44.2] μmol/(kg×min×mm Hg); CPK leakage — 95.8 [93.7; 111.3] IU/l. After 15 hours of perfusion, the level of glucose consumption by isolated hearts per unit of performed function increased significantly to 136.8 [130.5; 145.7] μmol/(kg×min×mm Hg), p=0.01208; lactate excretion and CPK leakage into the perfusate increased to 58.2 [55.7; 67.4] μmol/(kg×min×mm Hg), p=0.02144, and 229.7 [215.8; 242.4] IU/L respectively, p=0.01208. CONCLUSION: The study showed that extracorporeal perfusion of the heart in the developed device allows maintaining its viability for 12 hours in conditions maximally close to physiological ones, and also conducting dynamic assessment of the functional and metabolic state of the organ.

16 March 2026 in Transplantologiya. The Russian Journal of Transplantation
Verified
Journal Article
Open access
PDF file
ПЕП. А. Ермолаев
П. А. Ермолаев
TKT. P. Khramykh
T. P. Khramykh
AKA. A. Kuznetsov
A. A. Kuznetsov
IBI. R. Barkhatov
I. R. Barkhatov
VTV. N. Tsekhanovich
V. N. Tsekhanovich
Introduction. Extracorporeal perfusion of transplants is proposed as one of the areas to expand the pool of donor hearts. Important aspects are the establishment of optimal perfusion parameters, which is of particular importance in prolonged perfusion. Objective. To present the results of the development of a perfusion module for extracorporeal anti-ischemic protection of donor hearts. Material and methods. A perfusion module for extracorporeal anti-ischemic protection of donor hearts was developed on mature outbred male rats. After 12-hour hypothermic extracorporeal perfusion of the heart in the perfusion module with +8°С oxegenated HTK solution, its function was studied. Results. In the hypothermic perfusion group on the module, sinus rhythm was observed with a heart rate of 268.5 (256.2;279.0) beats/min; the left ventricle-developed pressure (LVDP) was 65.5 (65.0;70.7) mm Hg, by the end of the 1 st hour, the LVDP was 73.0 (70.5;75.0) mm Hg, after 90 minutes the LVDP was 82.0 (80.5;83.5) mm Hg, by the end of the 2 nd hour, the LVDP was 82.5 (80.5;84.0) mm Hg, which indicated the cardioprotective potential of hypothermic perfusion. The hearts of the control group had sinus bradycardia with a heart rate of 113.5 (90.0;124.7) beats per minute. The LVDP was 27.5 (25.5;30.0) mm Hg by the end of the 30-minute cardiac stabilization period; by the end of the 1 st hour, LVDP was 22.0 (20.5;23.7) mm Hg; by the 90 th minute the contractile function of the hearts was absent, which indicated the development of myocardial damage. Conclusion. Obtained data indicate that the module can maintain the viability of the donor heart for 12 hours by hypothermic perfusion with +8°С oxygenated HTK solution at flow rate of 0.3 ml/min and pressure of 10 cm H 2 O and pO 2 600-700 mm Hg, which is accompanied by heart rate of 325.0 beats/min and LVDP of 82.5 mm Hg, compared to non-perfusion conservation.

31 July 2024 in Sechenov Medical Journal
Verified
Journal Article
Open access
PDF file
PEP. A. Ermolaev
P. A. Ermolaev
TKT. P. Khramykh
T. P. Khramykh
AVA. S. Vyaltsin
A. S. Vyaltsin
LBL. O. Barskaya
L. O. Barskaya
Aim. To test in experiment a pathogenetically adequate model of brain death due to increased intracranial pressure with gradual induction, allowing the evaluation of the changes occurring in the organs of a potential donor.Materials and methods. 6–8 months old outbred male rats of the experimental group (n = 18) and the control group (n = 8) were anesthetized, the left common carotid artery was catheterized to record systolic, diastolic blood pressure (BP) and heart rate (HR), the mean BP (MBP) was calculated. After transfer to artifi cial ventilation, brain death was simulated in the experimental group using the developed method.Results. All animals in the experimental group suffered brain death 30 minutes from the start of the experiment;10 rats (56%) died within 3 hours due to progression of circulatory failure. Initially, in anesthetized animals, MBP was 101 (90; 105) mm Hg, HR 310 (297; 315) beats/min. After 5 minutes from the start of brain death induction, MBP increased to 147 (140; 150) mm Hg (p = 0.01), HR to 396 (384; 406) beats/min (p = 0.03). Further, within 20 minutes there was a decrease in MBP to 94 (90; 100) mm Hg and HR to 290 beats/min. During the observation period from 26 to 90 minutes, there was a stabilization of MBP at the level of 87–92 mm Hg, there was a tendency to bradycardia with HR from 263 to 274 beats/min (p = 0.01). Then after 120–150 minutes from the beginning of brain death induction, MBP continued to decrease to 75–80 mmHg (p = 0,03), HR to 256–264 beats/min (p = 0,01). At the end of the experiment, despite volemic support, MBP decreased to 64 (61; 67) mm Hg (p = 0.02), bradycardia worsened with HR to 250 (248; 260) beats/min (p = 0.01), indicating the hemodynamic decompensation.Conclusion. The results of experimental testing of an animal brain death model on outbred rats showed that this model is pathogenetically adequate and useful to assess the condition of potential donor organs within 3 hours after the induction of brain death.